CoQ10: A Natural Solution for Countering Statin Side Effects and Promoting Heart Health

Coenzyme Q10 (CoQ10), a fat-soluble compound found in living organisms, plays pivotal roles in cellular energy production and antioxidant defense. However, the body’s ability to produce CoQ10 diminishes with age, often starting in our late twenties or early thirties. Although our bodies can synthesize CoQ10 from amino acids, this process relies on several vitamins, including B2, B3, B5, B6, B12, and vitamin C, as essential cofactors. Dietary sources provide minimal amounts, predominantly found in meat and animal organs, which can be a challenge for vegetarians [1].

Health Implications of Deficiency in CoQ10

The heart is one of the organs with the highest concentration of CoQ10. A deficiency can weaken the heart’s ability to pump blood effectively and may contribute to cardiovascular problems, including heart failure.

CoQ10 is also vital for muscle health, and a deficiency can lead to muscle weakness and pain. It is often associated with statin-induced muscle symptoms (SAMS), a potential side effect of cholesterol-lowering statin medications.

CoQ10 Improves the Side Effects of Statin Drugs

CoQ10 synthesis takes place within our body’s mevalonate pathway, a biochemical process responsible for producing essential compounds like cholesterol [2]. Ironically, when individuals take statin drugs to lower cholesterol levels, they inhibit a crucial step within this pathway. While this effectively reduces cholesterol, it can unintentionally decrease CoQ10 levels. Considering CoQ10’s pivotal role in cellular energy production and muscle health, this unintended consequence of statin drugs can significantly impact overall well-being [3].

Research shows that people on statins indeed have lower CoQ10 levels compared to those not on medication. Lab experiments have confirmed statins’ impact on CoQ10 production [4].

Two recognized primary side effects of statin drugs are statin-associated muscle symptoms and an increased risk of heart failure.

Statin-associated muscle symptoms (SAMS) affect 7-29% of statin users, making them the most common side effects, comprising about two-thirds of all statin-related side effects [2]. In 2018, two meta-analyses were published. One, involving 1,776 participants in 12 clinical trials, found that regardless of the statin dosage, CoQ10 levels decreased with statin use [5]. Another study, with 575 patients in 12 clinical trials experiencing statin-induced muscle weakness, showed that CoQ10 supplementation helped alleviate these symptoms [6].

However, not all studies agree. Some suggest CoQ10 supplements may not consistently relieve SAMS, as these symptoms may not solely be linked to CoQ10 levels [7]. For instance, CoQ10 might reduce vitamin D levels, and restoring normal vitamin D levels has also alleviated SAMS symptoms in some cases [8].

One notable recent study is the 2014 Q-SYMBIO trial, where 420 chronic heart failure patients took 300mg of CoQ10 (Myoqinon) daily for two years. Results showed improved cardiac health indicators and a significant reduction in cardiovascular events compared to the control group [9].

In a separate year-long study involving 640 participants with an average age of 67, daily CoQ10 supplementation (2mg/kg body weight) led to fewer heart failure hospitalizations and reduced severe cardiovascular events in the intervention group compared to the control group [10]. Overall, there is substantial evidence suggesting CoQ10 can lower the risk of statin-induced heart failure and potentially ease statin-related muscle symptoms, though results vary.

How to Supplement CoQ10

When it comes to dosing, clinical research has shown the safety of CoQ10 with daily doses of up to 1200mg for extended periods of 16 months without significant side effects. [11]

CoQ10 is a fat-soluble, large molecule with relatively limited absorption in the intestines. Its absorption can be improved when taken alongside fatty foods. CoQ10 primarily exists in two forms: ubiquinol (the reduced form) and ubiquinone (the oxidized form). Ubiquinol is often referred to as “active” CoQ10. In practice, during redox processes, CoQ10 continuously undergoes oxidation-reduction-oxidation cycles in electron transfer. Many online opinions suggest that ubiquinol is better absorbed and more effective. Indeed, certain human clinical studies have indicated higher bioavailability for ubiquinol compared to ubiquinone CoQ10. [12]

Summary

CoQ10 is a vital fat-soluble compound found in living organisms, playing essential roles in energy production and antioxidant defense.

Aging reduces our body’s ability to produce CoQ10, potentially affecting heart health and muscle function, with the heart being particularly vulnerable.

Statin drugs, used to lower cholesterol, inadvertently decrease CoQ10 levels due to their impact on the mevalonate pathway, potentially leading to side effects like muscle weakness and heart problems.

Research shows mixed results regarding CoQ10’s ability to alleviate statin-related muscle symptoms (SAMS), but it remains a promising option.

Prominent clinical trials have highlighted CoQ10’s potential in improving cardiac health and reducing cardiovascular events.

To supplement CoQ10 effectively, consider factors like dosage, absorption with fatty foods, and the choice between ubiquinol and ubiquinone forms, with ubiquinol potentially having higher bioavailability.

References:

[1] Know,L. (2018), Mitochondria and the Future of Medicine: The Key to Understanding Disease, Chronic Illness, Aging, and Life Itself, Vermont: Chelsea Green Publishing

[2] Kennedy, Cormac et al. (2020). Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis. Atherosclerosis. 299. 10.1016/j.atherosclerosis.2020.03.006.

[3] McGregor, Grace et al.  (2019). Targeting the Metabolic Response to Statin-Mediated Oxidative Stress Produces a Synergistic Antitumor Response. Cancer Research. 80. canres.0644.2019. 10.1158/0008-5472.CAN-19-0644.

[4] Gurha, Neha et al. (2020). Association of statin induced reduction in serum coenzyme Q10 level and conduction deficits in motor and sensory nerves: An observational cross-sectional study. Clinical Neurology and Neurosurgery. 196. 106046. 10.1016/j.clineuro.2020.106046.

[5] Qu, H. et al.  (2018). Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 7(19), e009835. https://doi.org/10.1161/JAHA.118.009835

[6] Qu, H. et al.  (2018). The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials. European journal of medical research, 23(1), 57. https://doi.org/10.1186/s40001-018-0353-6

[7] Zaleski, A. L., Taylor, B. A., & Thompson, P. D. (2018). Coenzyme Q10 as Treatment for Statin-Associated Muscle Symptoms-A Good Idea, but…. Advances in nutrition (Bethesda, Md.), 9(4), 519S–523S. https://doi.org/10.1093/advances/nmy010

[8] Turner, Richard & Pirmohamed, Munir. (2019). Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components. Journal of clinical medicine. 9. 10.3390/jcm9010022.

[9] Mortensen, S. A. et al.  (2014). The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC. Heart failure, 2(6), 641–649. https://doi.org/10.1016/j.jchf.2014.06.008

[10] Morisco, C., Trimarco, B., & Condorelli, M. (1993). Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. The Clinical investigator, 71(8 Suppl), S134–S136. https://doi.org/10.1007/BF00226854

[11] Shults, C. W. et al.  (2002). Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Archives of neurology, 59(10), 1541–1550. https://doi.org/10.1001/archneur.59.10.1541

[12] Langsjoen, P. H., & Langsjoen, A. M. (2014). Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone. Clinical pharmacology in drug development, 3(1), 13–17. https://doi.org/10.1002/cpdd.73